The molecular genetic approach to malarial pathogenesis and immunity

Parassitologia

Volumn 41, Issue 1-3, 1999, Pages 233-240

  Kwiatkowski, D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Disease associated polymorphisms; Immunity; Molecular genetics; Pathogenesis; Severe malaria

Indexed keywords

ANIMAL; ERYTHROCYTE; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALARIA; PARASITOLOGY; PATHOGENICITY; PLASMODIUM; REVIEW;

ANIMALS; ERYTHROCYTES; HUMANS; IMMUNITY, NATURAL; MALARIA; PLASMODIUM;

EID: 0033181974     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Abel L, Cot M, Mulder L, Carnevale P, Feingold J (1992). Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am J Hum Genet 50: 1308-1317.
2. Adams JH, Hudson DE, Torii M, Ward GE, Wellems TE, Aikawa M, Miller LH (1990). The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63: 141-153.
3. Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL (1996). Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184: 557-567
4. Bellamy R, Kwiatkowski D, Hill AV (1998). Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene potymorphisms and severe malaria in a West African population Trans R Soc Trop Med Hyg 92: 312-316.
5. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, et al. (1995). Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9: 284-292.
6. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K (1989) Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium faiciparum. Nature 341: 57-59
7. Brewster DR, Kwiatkowski D, White NJ (1990). Neurological sequelae of cerebral malaria in children. Lancet 336: 1039-1043.
8. Burgner D, Xu W, Rockett K, Gravenor M, Charles IG, Hill AV, Kwiatkowski D (1998). Inducible nitric oxide synthase polymorphism and fatal cerebral malaria [letter]. Lancet 352: 1193-1194
9. Cabrera M, Shaw M-A, Sharples C, Williams H, Castes M, Convit J, Blackwell JM (1995) Polymorphism in tumor necrosis factor genes is associated with mucocutaneous leishmaniasis J Exp Med 182 1259-1264.
10. Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH (1996). The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 184: 1531-1536.
11. Clark IA, al-Yaman FM, Cowden WB, Rockett KA (1996). Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa? Lancet 348: 1492-1494
12. Clark IA, Chaudhri G (1988). The balance of useful and harmful effects of TNF, with special reference to malaria Ann Inst Pasteur Immunol 139: 305-306.
13. Clark IA, Rockett KA, Cowden WB (1992). Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 340: 894-896
14. Collins FS, Guyer MS, Chakravati A (1997). Variations on a theme cataloguing human DNA sequence variation. Science 278 1580-1581.
15. Davenport MP, Hill AV (1996). Reverse immunogenetics from HLA-disease associations to vaccine candidates. Mol Med Today 2: 38-45.
16. Fernandez-Reyes D, Craig AG, Kyes SA, Peshu N, Snow RW, Berendt AR, Marsh K, Newbold CI (1997). A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 6: 1357-1360.
17. Flint J, Hill AV, Bowden DK, Oppenheimer SJ, Sill PR, Serjeantson SW, Bana-Koiri J, Bhatia K, Alpers MP, Boyce AJ, et al. (1986) High frequencies of alpha-thalassaemia are the result of natural selection by malaria Nature 321: 744-750
18. Genton B, al-Yaman F, Mgone CS, Alexander N, Paniu MM, Alpers MP, Mokela D (1995). Ovalocytosis and cerebral malaria [letter]. Nature 378: 564-565.
19. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P (1987). Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210-1212
20. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH (1989). Tumor necrosis factor and disease severity in children with falciparum malaria N Engl J Med 320: 1586-1591.
21. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, Tulloch S, Oldfield FS., Hayes R (1987). Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 81: 478-486.
22. Hill AV (1992). Malaria resistance genes: a natural selection. Trans R Soc Trop Med Hyg 86: 225-226, 232.
23. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595-600.
24. Hill AV, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsend AR, et al (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434-439.
25. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH (1993). A receptor for the malarial parasite Plasmodium vivax the erythrocyte chemokine receptor. Science 261: 1182-1184.
26. Jepson AP, Banya WA, Sisay-Joof F, Hassan-King M, Bennett S, Whittle HC (1995). Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children. J Infect Dis 172: 316-319.
27. Knight JC, Udalova I, Hill AVS, Greenwood BM, Peshu N, Marsh K. Kwiatkowski D (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 22: 145-150.
28. Kun J, Mordmüller B, Lell B, Lehman L, Luckner D, Kremsner P (1998). Polymorphism in promoter region of inducible nitric oxide synthase and protection against malaria. Lancet 351: 265-266.
29. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L (1998). Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768-1772.
30. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336 1201-1204.
31. Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265: 2037-2048.
32. Maitland K, Williams TN, Peto TE, Day KP, Clegg JB, Weatherall DJ, Bowden DK (1997) Absence of malaria-specific mortality in children in an area of hyperendemic malaria Trans R Soc Trop Med Hyg 91: 562-566
33. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D (1994). Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510.
34. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D (1999). Severe malarial anaemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 179: 287-290.
35. Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976). The resistance factor to Plasmodium vivax in blacks The Duffy-blood-group genotype, FyFy-N Engl J Med 295: 302-304
36. Modiano D, Chiucchiuini A, Petrarca V, Sirima BS, Luoni G, Perlmann H, Esposito F, Coluzzi M (1998) Humoral response to Plasmodium falciparum Pf155/ring-infected erythrocyte surface antigen and Pf332 in three sympatric ethnic groups of Burkina Faso Am J Trop Med Hyg 58 220-224
37. Modiano D, Petrarca V, Sirima BS, Bosman A, Nebie I, Diallo D, Lamizana L, Esposito F, Coluzzi M (1995) Plasmodium falciparum malaria in sympatric ethnic groups of Burkina Faso, West Africa Parassitologia 37 255-259.
38. Modiano D, Petrarca V, Sirima BS, Nebe I, Diallo D, Esposito F, Coluzzi M (1996). Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups Proc Natl Acad Sci USA 93: 13206-13211
39. Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, Msobo M, Peshu N, Marsh K (1997) Receptor-specific adhesion and clinical disease in Plasmodium falciparum Am J Trop Med Hyg 57: 389-398.
40. Rihet P, Abel L, Traore Y, Traore-Leroux T, Aucan C, Fumoux F (1998a). Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso. Genet Epidemiol 15: 435-450.
41. Rihet P, Traore Y, Abel L, Aucan C, Traore-Leroux T, Fumoux F (1998b). Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33 Am J Hum Genet 63: 498-505.
42. Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases Science 273: 1516-1517
43. Rowe JA, Moulds JM, Newbold CI, Miller LH (1997). P falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1 Nature 388: 292-295
44. Roy S, McGuire W, Mascie-Taylor CG, Saha B, Hazra SK, Hill AV, Kwiatkowski D (1997). Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 176: 530-532.
45. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, et al. (1995) Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376 246-249.
46. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516
47. Taverne J, Sheikh N, de Souza JB, Playfair JH, Probert L, Kollias G (1994). Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology 82: 397-403
48. Taverne J, Tavernier J, Fiers W, Playfair JH (1987). Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro Clin Exp Immunol 67: 1-4.
49. Tournamille C, Colin Y, Cartron JP, Le Van Kim C (1995). Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10 224-228
50. Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukritayakamee S, Nagachinta B, et al. (1994). An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration Am J Pathol 145: 1057-1069.
51. van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G, Memming H, Frenkel J, Enwere G, Bennett S, Kwiatkowski D, Greenwood B (1996). The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria J Infect Dis 174: 1091-1097.
52. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP, Vandenbrouke JP (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349 170-173.
53. Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TE, Newbold CI, Bowden DK, Weatherall DJ, Clegg JB (1996). High incidence of malaria in alpha-thalassaemic children. Nature 383: 522-525